{"id":46323,"date":"2026-07-28T16:00:00","date_gmt":"2026-07-28T14:00:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=b402ec57cda3f7a55950d06ae16de083"},"modified":"2026-07-28T16:00:00","modified_gmt":"2026-07-28T14:00:00","slug":"alkermes-plc-reports-second-quarter-2026-financial-results","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=46323","title":{"rendered":"Alkermes plc Reports Second Quarter 2026 Financial Results"},"content":{"rendered":"

DUBLIN--(BUSINESS WIRE)--Alkermes plc<\/a> (Nasdaq: ALKS) today reported financial results for the quarter ended June 30, 2026. To view the detailed second quarter 2026 earnings press release<\/a> and presentation, please visit the company\u2019s investor relations website at https:\/\/investor.alkermes.com<\/a>.<\/p><\/a><\/a>

\nAlkermes will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. BST) today, to discuss these financial results and expectations, and provide an update on the company. The webcast may be accessed on the Investors section of Alkermes\u2019 website at https:\/\/investor.alkermes.com<\/a>. The conference call may be accessed by dialing +1 877 407 2988 for U.S. callers and +1 201 389 0923 for international callers. In addition, a replay of the conference call may be accessed by visiting Alkermes\u2019 website.<\/p>

\nAbout Alkermes plc\n<\/span><\/b>Alkermes plc, a mid-cap growth and value equity, is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder and narcolepsy. Alkermes\u2019 pipeline includes late-stage clinical candidates in development for narcolepsy and idiopathic hypersomnia, and orexin 2 receptor agonists in early clinical development for other neurological disorders, including attention-deficit hyperactivity disorder (ADHD) and fatigue associated with multiple sclerosis and Parkinson\u2019s disease. Headquartered in Ireland, Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio. For more information, please visit Alkermes\u2019 website at www.alkermes.com<\/a>.<\/p> Contacts<\/b>

\nAlkermes Contacts:<\/span>For Investors: Sandy Coombs +1 781 609 6377\nFor Media: Katie Joyce +1 781 249 8927<\/p>","protected":false},"excerpt":{"rendered":"

DUBLIN–(BUSINESS WIRE)–Alkermes plc (Nasdaq: ALKS) today reported financial results for the quarter ended June 30, 2026. To view the detailed second quarter 2026 earnings press release and presentation, please visit the company\u2019s investor relations w…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-46323","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/46323","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=46323"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/46323\/revisions"}],"predecessor-version":[{"id":46324,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/46323\/revisions\/46324"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=46323"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=46323"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=46323"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}